October 18, 2025 - 17:18

As Halloween approaches, consumers are feeling the pinch from soaring cocoa prices, leading to more expensive candy options. A recent analysis highlights the reasons behind the steep increase in cocoa costs, which is largely attributed to supply chain disruptions and fluctuating demand. These factors are causing manufacturers to pass on the higher prices to consumers, making it essential for families to consider their candy purchases carefully this year.
With the holiday season on the horizon, many are searching for ways to save on treats without sacrificing the festive spirit. Shoppers may want to explore bulk buying options or consider alternative sweets that are not reliant on cocoa. Additionally, planning ahead and comparing prices at different retailers can help mitigate the impact of rising candy prices.
As families prepare for Halloween festivities, being mindful of spending while still enjoying the season will be crucial in navigating the current market landscape.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...